Journal article
Management of Small Bowel Neuroendocrine Tumors
Surgical oncology clinics of North America, Vol.29(2), pp.223-241
04/01/2020
DOI: 10.1016/j.soc.2019.11.006
PMID: 32151357
Abstract
Small bowel neuroendocrine tumors (SBNETS) are slow-growing neoplasms with a noted propensity toward metastasis and comparatively favorable prognosis. The presentation of SBNETs is varied, although abdominal pain and obstructive symptoms are the most common presenting symptoms. In patients with metastases, hypersecretion of serotonin and other bioactive amines results in diarrhea, flushing, valvular heart disease, and bronchospasm, termed carcinoid syndrome. The treatment of SBNETs is multimodal and includes surgery, liver-directed therapy, somatostatin analogues, targeted therapy, and peptide receptor radionuclide therapy.
Details
- Title: Subtitle
- Management of Small Bowel Neuroendocrine Tumors
- Creators
- Aaron T. Scott - Roy J. and Lucille A. Carver College of MedicineJames R. Howe - Roy J. and Lucille A. Carver College of Medicine
- Resource Type
- Journal article
- Publication Details
- Surgical oncology clinics of North America, Vol.29(2), pp.223-241
- Publisher
- Elsevier
- DOI
- 10.1016/j.soc.2019.11.006
- PMID
- 32151357
- ISSN
- 1055-3207
- eISSN
- 1558-5042
- Number of pages
- 20
- Grant note
- CA148062-0 / T32 grant P50 CA174521-01 / SPORE grant
- Language
- English
- Date published
- 04/01/2020
- Academic Unit
- Surgery
- Record Identifier
- 9984322797002771
Metrics
5 Record Views